vs
Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
KINGSTONE COMPANIES, INC. is the larger business by last-quarter revenue ($56.4M vs $31.1M, roughly 1.8× LIFECORE BIOMEDICAL, INC. \DE\). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs -32.1%, a 58.3% gap on every dollar of revenue. On growth, KINGSTONE COMPANIES, INC. posted the faster year-over-year revenue change (34.0% vs -4.5%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $25.0K). Over the past eight quarters, KINGSTONE COMPANIES, INC.'s revenue compounded faster (25.6% CAGR vs -0.1%).
Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
KINS vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $56.4M | $31.1M |
| Net Profit | $14.8M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 32.7% | -9.9% |
| Net Margin | 26.2% | -32.1% |
| Revenue YoY | 34.0% | -4.5% |
| Net Profit YoY | 171.4% | -52.0% |
| EPS (diluted) | $1.09 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.4M | — | ||
| Q3 25 | $55.7M | $31.1M | ||
| Q2 25 | $52.3M | — | ||
| Q1 25 | $50.5M | $35.2M | ||
| Q4 24 | $42.1M | $32.6M | ||
| Q3 24 | $40.8M | $24.7M | ||
| Q2 24 | $36.5M | — | ||
| Q1 24 | $35.8M | $35.7M |
| Q4 25 | $14.8M | — | ||
| Q3 25 | $10.9M | $-10.0M | ||
| Q2 25 | $11.3M | — | ||
| Q1 25 | $3.9M | $-14.8M | ||
| Q4 24 | $5.4M | $-6.6M | ||
| Q3 24 | $7.0M | $-16.2M | ||
| Q2 24 | $4.5M | — | ||
| Q1 24 | $1.4M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 32.7% | — | ||
| Q3 25 | 24.6% | -9.9% | ||
| Q2 25 | 27.1% | — | ||
| Q1 25 | 9.3% | -25.7% | ||
| Q4 24 | 15.9% | -6.0% | ||
| Q3 24 | 22.3% | -46.9% | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 5.0% | -2.5% |
| Q4 25 | 26.2% | — | ||
| Q3 25 | 19.5% | -32.1% | ||
| Q2 25 | 21.5% | — | ||
| Q1 25 | 7.7% | -42.0% | ||
| Q4 24 | 12.9% | -20.2% | ||
| Q3 24 | 17.1% | -65.7% | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 4.0% | 43.8% |
| Q4 25 | $1.09 | — | ||
| Q3 25 | $0.74 | $-0.29 | ||
| Q2 25 | $0.78 | — | ||
| Q1 25 | $0.27 | $-0.47 | ||
| Q4 24 | $0.44 | $-0.25 | ||
| Q3 24 | $0.55 | $-0.53 | ||
| Q2 24 | $0.37 | — | ||
| Q1 24 | $0.12 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | $4.4M | $136.0M |
| Stockholders' EquityBook value | $122.7M | $-10.5M |
| Total Assets | $453.4M | $235.2M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $4.4M | — | ||
| Q3 25 | $4.8M | $136.0M | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $5.4M | $124.9M | ||
| Q4 24 | $11.2M | $111.3M | ||
| Q3 24 | $17.3M | $106.3M | ||
| Q2 24 | $25.3M | — | ||
| Q1 24 | $25.3M | $97.1M |
| Q4 25 | $122.7M | — | ||
| Q3 25 | $107.7M | $-10.5M | ||
| Q2 25 | $94.9M | — | ||
| Q1 25 | $82.2M | $2.2M | ||
| Q4 24 | $66.7M | $15.4M | ||
| Q3 24 | $59.7M | $-3.9M | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | $35.7M | $17.7M |
| Q4 25 | $453.4M | — | ||
| Q3 25 | $428.6M | $235.2M | ||
| Q2 25 | $393.4M | — | ||
| Q1 25 | $385.4M | $237.7M | ||
| Q4 24 | $374.9M | $255.4M | ||
| Q3 24 | $347.0M | $246.8M | ||
| Q2 24 | $319.8M | — | ||
| Q1 24 | $318.3M | $246.2M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.07× | 56.05× | ||
| Q4 24 | 0.17× | 7.20× | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.71× | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.9M | $1.8M |
| Free Cash FlowOCF − Capex | $73.1M | $25.0K |
| FCF MarginFCF / Revenue | 129.5% | 0.1% |
| Capex IntensityCapex / Revenue | 5.0% | 5.6% |
| Cash ConversionOCF / Net Profit | 5.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $124.0M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.9M | — | ||
| Q3 25 | $25.9M | $1.8M | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $17.9M | $1.2M | ||
| Q4 24 | $57.9M | $-6.1M | ||
| Q3 24 | $21.7M | $-613.0K | ||
| Q2 24 | $7.1M | — | ||
| Q1 24 | $6.1M | $-1.4M |
| Q4 25 | $73.1M | — | ||
| Q3 25 | $25.3M | $25.0K | ||
| Q2 25 | $8.7M | — | ||
| Q1 25 | $17.0M | $-4.3M | ||
| Q4 24 | $55.6M | $-8.6M | ||
| Q3 24 | $21.0M | $-4.0M | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $5.6M | $-7.8M |
| Q4 25 | 129.5% | — | ||
| Q3 25 | 45.4% | 0.1% | ||
| Q2 25 | 16.6% | — | ||
| Q1 25 | 33.7% | -12.1% | ||
| Q4 24 | 132.1% | -26.3% | ||
| Q3 24 | 51.6% | -16.3% | ||
| Q2 24 | 18.1% | — | ||
| Q1 24 | 15.5% | -21.8% |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 1.2% | 5.6% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.7% | 15.5% | ||
| Q4 24 | 5.6% | 7.5% | ||
| Q3 24 | 1.7% | 13.9% | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.5% | 17.8% |
| Q4 25 | 5.14× | — | ||
| Q3 25 | 2.38× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 4.60× | — | ||
| Q4 24 | 10.65× | — | ||
| Q3 24 | 3.12× | — | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KINS
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
